Home / Inspections / 1243362

FDA Inspection 1243362 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 1416980

The FDA completed an inspection of Baxter Healthcare Corporation on August 1, 2024 in Round Lake, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Round Lake, IL (United States)

Facility

Other inspections at this facility

  • 1311078 (OAI Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215194 (VAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024072 (VAI Fri Jul 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007331 (NAI Wed Mar 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 996518 (NAI Thu Dec 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources